Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Cincinnati, Ohio 45220


Liposomal bupivacaine or placebo will be administered at the end of a transobturator midurethral sling to determine if there is a difference in a patient's perceived postoperative pain.

Study summary:

The investigators aim to evaluate the use of liposomal bupivacaine to reduce postoperative pain from placement of transobturator slings for the treatment of stress urinary incontinence.


Inclusion Criteria: - Adults > 18 years of age - Planning for outpatient surgical treatment of SUI with placement of a transobturator suburethral sling under general anesthesia Exclusion Criteria: - Pregnant or nursing - Allergy to bupivacaine - History of drug/alcohol abuse - Severe cardiovascular, hepatic, renal disease, or neurological impairment° - Long-acting opioid within 3 days or any opioid use within 24 hours before surgery - Contraindication to: - acetaminophen - oxycodone - non-steroidal anti-inflammatory drugs (NSAID) - Administration of an investigational drug within 30 days before study - Chronic pain syndromes - Daily NSAID/opioid use - Patients having concomitant procedures or not undergoing general anesthesia - Patients who require a concomitant anterior repair or urethrocele repair will not be excluded as this requires the same dissection in the anterior vaginal wall.



Primary Contact:

Principal Investigator
Catrina C Crisp, MD
TriHealth Inc.

Backup Contact:


Location Contact:

Cincinnati, Ohio 45220
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.